Persented by: Dr. Enas futaisi When to suspect vasculitis Multi-system involvement Unexplained fever, weight loss. Unexplained raised ESR or CRP Occlusive arterial disease or hypertension in young adults. Cerebrovascular/cardiovascular events in young. Unexplained proteinuria with or without casts. Splinter haemorrhages in nails • Cutaneous lesions - palpable purpura, erythema, subcutaneous nodules or urticaria. Sudden retinal vascular disease without hypertension or diabetes Sudden appearance of peripheral neuropathy - wrist drop, foot drop. Unexplained finding of pulmonary nodular/cavitatory lesions. Persistent headache with sudden visual impairment (monocular blindness) in elderly. Jaw claudication History -chronicity (acute vs. chronic) -exposures to drugs, vaccines,chemicals – risk factors for Hep B/C/HIV – history of valvular heart disease - asthma Any :- -sinus problems skin rash , photosensitivity -nose bleeds mouth ulcers , hair loss deafness dry / gritty eyes , dry mouth haemoptysis Raynauds , pleuritic pain pins / needles blood clots , miscarriages • Any malignancy Drugs -weight loss • Cocaine -night Sweats • Phenytoin CTD?- photosensitivity, oral lesions, muscle • Sulfa drugs wkns • Penicillins -fevers • Hydralazine • Allopurinol • Symptoms suggestive of systemic vasculitis • Propylthiouracil Systemic - malaise, fever, wt loss myalgia, arthralgia Skin - purpura (palpable) • Thiazides Physical Exam Diagnostic approach 1.Complete History & Physical Examination ulceration, infarction • ENT - epistaxis, crusting sinusitis, deafness • Resp - cough, wheeze haemoptysis, dyspnoea • Cardiac - chest pain, SOB • GI - mouth ulcers, abdo pain, diarrhoea • Neuro - sensory/motor impairment • Many syndromes are based on clinical rather than lab criteria • Principle historical & clinical features help to distinguish the major vasculitic syndromes Laboratory Investigations Assessing Inflammation • Liver function • Blood count & differential - often non specific – total WCC - may also suggest viral - leucocytosis consistent with infection & infection primary vasculitis -leucopaenia associated with CTD’s - eosinophils - elevated in CSS, drug reaction • Acute phase response ESR/CRP Assessment of organ involvement • Chest radiograph • Urine analysis • Liver function - proteinuria • Nervous system - NCS - haematuria • Cardiac function - ECG - Echo - casts • Gut - Angiography • Renal function - creatinine clearance - 24hr prot ein excretion - biopsy Immunological Tests • Anti-neutrophil cytoplasmic antibodies – proteinase 3 – myeloperoxidase • Other autoantibodies – Rheumatoid factor – ANA nuclear antibodies – Antibodies to extractable nuclear antigens – Anti ds DNA – Anticardiolipin • Complement - levels are low in SLE and infection but high in primary vasculitis • Cryoglobulins Differential diagnosis • Important to exclude infection and other conditions that may present as multi-system disease & mimic vasculitis • Blood cultures • Viral serology • Echo cardiography Specific Investigations • Imaging of sinuses • Biopsy of affected organs eg. skin/kidney/temporal artery – necessary to confirm diagnosis Anti-Neutrophil Cytoplasmic Antibodies • Diagnosis & classisification of vasculitis has been revolutionised by discovery & characterisation of ANCA • Two types of ANCA staining patterns are seen on immunofluorescence (IF), namely cytoplasmic (c-ANCA) and perinuclear (p-ANCA). • ELISA should then always be performed in patients with positive results on immunofluorescence (IF) to identify the specific antigen targeted by ANCA • Presence of c-ANCA with anti-proteinase 3 (anti-PR3) is highly suggestive of Wegener’s granulomatosis while p- ANCA with anti-myeloperoxidase (anti-MPO) is more often encountered in those Churg-Strauss syndrome and microscopic polyangiitis • 2 main staining patterns – cytoplasmic C ANCA – perinuclear P ANCA • Highly specific markers for several systemic vasculidities – Wegners Granulomatosis – microscopic polyangitis – Churg-Strauss syndrome – idiopathic pauci-immune necrotising & cresenteric GN • Only moderately sensitive in limited or localised disease • c ANCA correlates with proteinase 3 specificity – most frequently observed in WG – sensitivity for active WG approx 90% – can be found in other systemic vasculitis although p ANCA more common • Anti PR3 ANCA may have role in disease pathogenesis in WG probably by enhancing disease expression • In stable WG patients a rise in c ANCA may herald a clinical exacerbation • p ANCA in most cases induced by antibodies against myeloperoxidase (MPO) – less specific than c ANCA – Anti MPO antibodies occur in:- • necrotising GN (65%) • microscopic polyangitis (45%) • CSS (60%) • Wegners (10%) – can also occur in other conditions but target antigen rarely MPO • RA IBD • Malignancy Infection The Biopsy Biospy newest lesion Document LCV size of vessels involved granulomatous inflamm (CSS orWG) lymphocyte rich infiltrate (CTD) immunofluorescence? Cutaneous small vessel vasculitis (CSVV) showing angiocentric segmental inflammation, endothelial swelling, neutrophilic infiltrate with leukocytoclasia, and fibrinoid necrosis of blood vessel walls.